Ketorolac Aurobindo

Ketorolac Trometamol, the active ingredient in Ketorolac Aurobindo, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an injectable solution for intramuscular or intravenous use. It provides short‑term relief of moderate to severe acute pain, including post‑operative pain, in adult patients requiring rapid analgesia.

GNH USA supplies Ketorolac Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global healthcare facilities. Clients benefit from consistent product availability and regulatory compliance across EU and other markets.

Ketorolac Aurobindo, an NSAID analgesic, is used for conditions involving acute nociceptive pain.

- Post‑operative pain: provides rapid analgesia to facilitate recovery after surgical procedures. - Acute musculoskeletal pain: reduces pain intensity following injury or strain. - Severe acute pain (e.g., after trauma): offers short‑term relief when opioid therapy is not required.

Ketorolac Aurobindo may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional emesis after dosing. - Dyspepsia: discomfort or burning in the upper abdomen. - Headache: transient cranial pain. - Dizziness: light‑headed sensation. - Injection site pain: local discomfort at the administration site.

Serious or Rare Side Effects: - Gastrointestinal bleeding: potentially life‑threatening hemorrhage. - Renal impairment: reduced kidney function or acute failure. - Cardiovascular events: increased risk of myocardial infarction or stroke. - Severe allergic reactions: anaphylaxis, angioedema, or skin rash. - Stevens‑Johnson syndrome: rare but serious skin disorder. - Hepatic dysfunction: elevated liver enzymes or hepatitis.

Ketorolac Aurobindo should be used with caution in patients with specific risk factors.

- Renal function: avoid or adjust dose in patients with impaired renal function. - Bleeding risk: use cautiously in individuals with active bleeding or on anticoagulants. - Gastrointestinal history: avoid in patients with peptic ulcer disease or recent GI bleeding. - Cardiovascular disease: use with caution in patients with coronary artery disease or hypertension. - Pregnancy: avoid in the third trimester and use only if benefits outweigh risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ketorolac Aurobindo can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin, DOACs): increased risk of serious bleeding. - Concurrent NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - SSRIs or SNRIs: heightened bleeding tendency. - Lithium: potential elevation of lithium serum levels.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion when combined. - Diuretics: possible decline in renal function. - Methotrexate: reduced clearance leading to toxicity.